Harry Lander

Harry Lander

Chief Executive Officer bij Canary Oncoceutics, Inc.

Vermogen: 193 613 $ op 31-03-2024

58 jaar
Health Technology
Consumer Services
Health Services

Profiel

Harry M.
Lander
is currently the Chief Executive Officer at Canary Oncoceutics, Inc., the Director at Federation Employment & Guidance Service, Inc., and the Director at Capo Therapeutics, Inc. Previously, he held the position of President, Director & Chief Scientific Officer at Zander Therapeutics, Inc. from 2018 to 2019, and President & Chief Scientific Officer at Regen Biopharma, Inc. from 2015 to 2019.
He also served as the Head-Administration at Sidra Medical & Research Center.
In addition, he will be the Chief Scientific Officer at SYBLEU, Inc. from 2022 to 2024.
Dr. Lander obtained his undergraduate degree from Stony Brook University.
He also holds an MBA from The Leonard N Stern School of Business, which he received in 1991.
Furthermore, he earned a doctorate degree from Weill Cornell Graduate School of Medical Sciences in 1992.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
31-07-2023 3 309 000 ( 31.18% ) 188 613 $ 31-03-2024
06-11-2023 6 667 ( 0.02% ) 5 000 $ 31-03-2024

Actieve functies van Harry Lander

BedrijvenFunctieBegin
Director/Board Member 16-09-2009
Director/Board Member -
Chief Executive Officer -
Alle actieve functies van Harry Lander

Eerdere bekende functies van Harry Lander

BedrijvenFunctieEinde
SYBLEU INC. Chief Tech/Sci/R&D Officer 12-04-2024
REGEN BIOPHARMA, INC. President 22-01-2019
President 22-01-2019
Chief Administrative Officer -
Ervaring van Harry Lander in detail bekijken

Opleiding van Harry Lander

Stony Brook University Undergraduate Degree
The Leonard N Stern School of Business Masters Business Admin
Weill Cornell Graduate School of Medical Sciences Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Harry Lander in detail bekijken

Connecties

100 +

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
REGEN BIOPHARMA, INC.

Health Technology

Bedrijven in privébezit6

Health Services

Commercial Services

Health Technology

Health Technology

SYBLEU, Inc.

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Harry Lander